Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
The Lancet. Haematology|December 8, 2019
Assessing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor statesLukasz P Gondek, Amy E DeZernBlood Advances|February 26, 2020
Stem cell donors should be screened for CHIPAmy E DeZern, Lukasz P GondekCurrent Hematologic Malignancy Reports|August 1, 2014
I walk the line: how to tell MDS from other bone marrow failure conditionsLukasz P Gondek, Amy E DeZernBritish Journal of Haematology|May 24, 2021
Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromesTheodoros Karantanos, Lukasz P Gondek, Ravi Varadhan, et al.Hematology. American Society of Hematology. Education Program|December 10, 2021
CHIP: is clonal hematopoiesis a surrogate for aging and other disease?Lukasz P GondekThe Journal of Clinical Investigation|October 15, 2019
Hitting the bullseye with a nonlethal payload: resistance in CD123-positive malignanciesLukasz P GondekHaematologica|October 16, 2025
Lenalidomide-associated reversible TP53-mutated clonal hematopoiesis in plasma cell neoplasmsChristian B Gocke, Mareike Peters, Christopher D Gocke, et al.Best Practice & Research. Clinical Haematology|August 18, 2021
Clonal hematopoiesis and bone marrow failure syndromesSergiu Pasca, Lukasz P GondekHematology. American Society of Hematology. Education Program|December 6, 2015
Nine years without a new FDA-approved therapy for MDS: how can we break through the impasse?Amy E DeZernHematology. American Society of Hematology. Education Program|December 10, 2021
Lower risk but high riskAmy E DeZernPageof 22